Correlation Between Acrivon Therapeutics, and ELYM Old
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and ELYM Old at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and ELYM Old into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and ELYM Old, you can compare the effects of market volatilities on Acrivon Therapeutics, and ELYM Old and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of ELYM Old. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and ELYM Old.
Diversification Opportunities for Acrivon Therapeutics, and ELYM Old
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Acrivon and ELYM is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and ELYM Old in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ELYM Old and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with ELYM Old. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ELYM Old has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and ELYM Old go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and ELYM Old
Given the investment horizon of 90 days Acrivon Therapeutics, is expected to generate 55.18 times less return on investment than ELYM Old. But when comparing it to its historical volatility, Acrivon Therapeutics, Common is 1.01 times less risky than ELYM Old. It trades about 0.0 of its potential returns per unit of risk. ELYM Old is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 362.00 in ELYM Old on October 16, 2024 and sell it today you would lose (53.00) from holding ELYM Old or give up 14.64% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 94.95% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. ELYM Old
Performance |
| Timeline |
| Acrivon Therapeutics, |
| ELYM Old |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Acrivon Therapeutics, and ELYM Old Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and ELYM Old
The main advantage of trading using opposite Acrivon Therapeutics, and ELYM Old positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, ELYM Old can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ELYM Old will offset losses from the drop in ELYM Old's long position.| Acrivon Therapeutics, vs. Aerovate Therapeutics | Acrivon Therapeutics, vs. Adagene | Acrivon Therapeutics, vs. Rezolute | Acrivon Therapeutics, vs. AN2 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |